Corealis Pharma Inc.
Roch Thibert is an experienced professional in the pharmaceutical industry, currently serving as the Executive Director of Pharmaceutical R&D at Corealis Pharma Inc. since September 2009. Prior to this role, Roch held the position of Senior Director of Pharmaceutical Development at the same company and served as Director of Formulation Development at ViroChem Pharma from April 2007 to April 2009. Roch's career also includes a tenure at Merck from 1997 to 2007 as Associate Director. Roch Thibert earned a Ph.D. in Pharmaceutical Sciences from Université de Montréal.
This person is not in any offices
Corealis Pharma Inc.
Corealis Pharma provides services on a contract basis in the areas of formulation and process development as well as in small-scale clinical trial material manufacturing and the packaging of solid dosage forms to pharmaceutical and biotech companies. Its services include API characterization, salt selection, pre-formulation, formulation and processdevelopment, analytical method development, stability storage, and testing, technical transfer and scale-up, cGMP manufacturing and packaging of phase I and II CTM, and dossier support.